SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trumps proposal to convert a planned Washington triumphal arch into a military complex for drones and rooftop snipers is the clearest immediate focal point, with supporters calling it a security measure and critics questioning its justification and cost. Broader discussion also links DJT to Iran-related tensions, higher fuel prices, and concerns about press restrictions, underscoring the tickers sensitivity to Trumps political and geopolitical actions.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is drawing attention after traders linked its sharp rally to the launch of confidential perpetual contracts powered by Hyperliquid, reinforcing its privacy, AI-agent, and cross-chain trading narrative. The community is broadly bullish and watching for further breakout momentum, though some traders view the move as a liquidity-driven pump and expect consolidation or a pullback.

Uranium Energy Corp. engages in the provision of uranium and titanium mining and related activities, including exploration, pre-extraction, extraction, and processing of uranium concentrates, and titanium minerals. It operates through the following geographical segments: Wyoming, Texas, Saskatchewan, and Others. The company was founded by Alan P. Lindsay and Amir Adnani on May 16, 2003 and is headquartered in Corpus Christi, TX.

Uranium Energy Corp

Recent quarterly results showing no uranium sales and a wider loss have put UEC under pressure, with traders questioning its valuation, production pace and near-term revenue. Bulls counter that the company is preserving inventory for potentially higher uranium prices and has substantial liquidity, no debt and expanding U.S. production tied to the broader nuclear-energy demand theme.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

China-related rare-earth supply restrictions and U.S. efforts to build domestic mine-to-magnet capacity are driving attention around MP Materials. Traders are split between bullish views on MPs government support, production ramp and magnet deliveries, and concerns that improved U.S.-China relations could ease supply pressure and weigh on the stock near term.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

A sharp move in AVAX is drawing attention amid heavy volume and traders focus on institutional adoption, including reported Charles Schwab access and NYSE testing of Avalanche for tokenized securities. Bulls view the RWA and tokenization narrative as a foundation for further momentum, while skeptics argue the move resembles another pump-and-dump and cite weak fees, inflation, and selling pressure.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Renewed attention is centered on Starknets privacy and BTCFi roadmap, particularly strkBTC, STRK20, and post-quantum infrastructure, with traders linking these developments to a recent breakout and stronger ecosystem activity. The community is broadly bullish on the technology and adoption potential, but some traders remain concerned about scheduled token unlocks, dilution, and weak price structure.

Block, Inc. engages in creating ecosystems for distinct customer audiences. It operates through the following segments: Square and Cash App. The Square segment provides payment services, software solutions, hardware, and financial services to sellers. The Cash App segment includes the financial tools available to individuals within the mobile Cash App, including peer-to-peer payments, bitcoin and stock investments. The company was founded by Jack Patrick Dorsey and James Morgan McKelvey in February 2009 and is headquartered in Oakland, CA.

Block Inc - Ordinary Shares - Class A

Block Inc

Blocks latest quarterly results and raised outlook are driving attention, with traders debating whether strong Cash App and Square growth, cost cuts, buybacks, and analyst upgrades outweigh concerns about softer forward momentum, user growth, credit exposure, and expenses. The reaction is divided between bullish expectations for a breakout and frustration over the stocks post-earnings weakness and long-running range-bound performance.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF

SpaceXs post-IPO weakness and expected lockup-related selling are dominating discussion, with traders saying the ETFs sizable SpaceX exposure is dragging the broader space basket lower. Long-term holders remain bullish on the space economy and are averaging down, while others criticize the funds management and question whether the sector can recover soon.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

Elevated diesel prices and exceptionally strong refining crack spreads, linked to global refinery disruptions and tight fuel supply, are driving attention to Valero and its refining peers. Traders remain split between viewing the margin surge as fundamental support for continued strength and warning that the shares are overbought and vulnerable to profit-taking, especially amid speculation about a U.S. diesel export ban.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

A strong quarterly report was overshadowed by slowing U.S. da Vinci procedure growth, conservative outlook commentary, tariff concerns, and intensifying competition, prompting a sharp post-earnings repricing. Traders are divided between viewing the selloff as an overreaction and attractive entry for a dominant, recurring-revenue business, versus arguing that its premium valuation still leaves room for further downside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kuehn Law Encourages Investors of CG Oncology, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of CG Oncology, Inc. to Contact Law Firm Kuehn Law Encourages Investors of CG Oncology, Inc. to Contact Law Firm PR Newswire NEW YORK, Aug. 19, 2026 NEW YORK, Aug. 19, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether...

CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue Estimates

CG Oncology, Inc. (CGON) delivered earnings and revenue surprises of -28.57% and -59.02%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure?

Equity

A potential AstraZeneca-Bristol Myers deal worth $400 billion would create one of the world’s largest drugmakers and combine major cancer franchises.

CG Oncology Stock Gains 12% in Three Months: What's Driving It?

CGON climbs as cretostimogene nears a planned 2026 BLA filing, posts encouraging phase II data. It maintains a cash position that supports operations through 2029.

The New Cancer Moonshot: Innovative Companies Pursuing Game-Changing Therapies

Cancer treatment is undergoing one of the most significant transformations in modern medical history.

RBC Capital Lifts PT on CG Oncology (CGON), Calls PIVOT-006 a Complex Catalyst

RBC Capital Lifts PT on CG Oncology (CGON), Calls PIVOT-006 a Complex Catalyst...

CG Oncology, Inc. (CGON) Reports Q1 Loss, Tops Revenue Estimates

CG Oncology, Inc. (CGON) delivered earnings and revenue surprises of -23.33% and +80.50%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Gilead Sciences (GILD) Tops Q1 Earnings and Revenue Estimates

Gilead (GILD) delivered earnings and revenue surprises of +7.68% and +0.95%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Wall Street Analysts Think CG Oncology, Inc. (CGON) Could Surge 29.78%: Read This Before Placing a Bet

The consensus price target hints at a 29.8% upside potential for CG Oncology, Inc. (CGON). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Are Medical Stocks Lagging  Brainsway (BWAY) This Year?

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and CG Oncology, Inc. (CGON) have performed compared to their sector so far this year.

CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Dallas, TX.

Cg Oncology Inc.

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Microsoft Corp

Meta Platforms Inc

SELLAS Life Sciences Group Inc

Alphabet Inc Class A

CoreWeave Inc

SpaceX

Stocktwits Polls

$CGON I bought this on a tip from a friend a year ago.  Added more around $32 and trimmed some at $62. Im  pretty much playing with the houses money and will let it ride until we moon.

Shred Abs

$CGON I think when we least expect it, this company will be snatched up by a much larger biopharmaceutical company.  Cheers to those that hold, good things coming!

Feed

News

Sentiment

Earnings

Fundamentals

Info

CGON Cg Oncology Inc.

Fundamentals

Latest CGON News